It’s an exciting time to work at Mallinckrodt. Our corporate culture is driven by five hallmarks: high-performing, competitive, collaborative, engaged and trustworthy. There’s a strong sense of purpose, too, as we’re all focused on helping patients. Our employees around the world are now driving forward a company working to reveal and relieve disease for a healthier world. Find out how much you’ll gain if you’re one of them.
Mallinckrodt Pharmaceuticals is pleased to bring Questcor and its entire business into our company.The former Questcor organization will be known as the Autoimmune and Rare Diseases business within Mallinckrodt’s Specialty Pharmaceuticals segment. Until January 2015 job opportunities for the Autoimmune and Rare Disease business can be found on another site: Autoimmune and Rare Diseases Careers or Job Listings.
Job opportunities in the other areas of Mallinckrodt Pharmaceuticals can be found on this site by utilizing the search feature below.
Step up. Explore ideas. Find better ways to do things. By taking personal responsibility for the success of our ambitious specialty pharmaceuticals and medical imaging business, you’ll really make a difference.
Being part of an organization that's creating its own destiny is priceless. Each of the functions in Business Operations will have a huge impact on how successful we become.
By developing products that provide clinical benefits across the globe, Clinical Affairs drives growth across the business. This is where we direct and manage Phase 1, 2 and 3 clinical studies to support product registrations.
EHS works globally to protect our people, our workplaces and our communities. The team members oversee radiation protection, environmental protection and health & safety in our plants and offices.
An array of complex scientific processes. A huge range of products. The relentless pursuit of innovation. Uncompromising standards.
Deliver long-term, above-market sales and earnings growth. Build on current net sales of over $2.2 billion.
Commercializing our products and making sure our customers - both patients and physicians - know how to access and use them safely and appropriately. That's the job of Medical Affairs.
All our products come with peace of mind. Vital when they have to swiftly relieve pain or accurately diagnose a life-threatening illness. No wonder quality is one of our core values or that we have such a strong Quality record.
Guiding new products to global approval. Keeping all our approved products in step with the world's ever-changing regulatory requirements.
R&D is our engine for growth. Shaping ideas into safer, better technologies to reveal and relieve disease, it makes sure our product pipeline is strong.
Many of our larger sites like St. Louis, Webster Grove, Maryland Heights, Raleigh; Cincinnati; Hobart, Dublin; Montreal and; Petten run internship programs.
It's not just the number of international container shipments we handle a year - around 2,500 by sea and 1,500 by air - that makes our work here so challenging.
In July 2013, Mallinckrodt Pharmaceuticals became an independent, publicly traded, $2.2 billion company. We're now driven by a new energy, led by highly motivated people and ready to build on a name that's synonymous with quality, integrity and service.
Our vision as an employer is to be the natural home of resourceful, enterprising people who are never afraid to ask "what if?" and "why not?" The more our people use their initiative, and the more wholeheartedly they collaborate to make changes, improvements and progress, the more effective we will be at providing patients with quality products that help create a healthier world.
Establishes its first office in New York City.
It’s an exciting time to be here. Our independence means we are now solely responsible for driving our own strategy, making changes that will help us work smarter and collaborating to achieve amazing things.
Hobart, New York
When I joined this business I never thought I'd still be here after all this time. I've enjoyed watching the Hobart site grow from a handful of people in the late 70s to the major employer it is today. And as I've been working with product development for over 25 years now, I know how much thought, planning, science and long hours go into getting regulatory approval. Looking ahead, there are several new products in development that I'd love to see in commercial production. The future of Mallinckrodt depends on a pipeline of new products and being part of that future is a reward in itself.
Why did Mallinckrodt Pharmaceuticals separate from Covidien?
Covidien and Mallinckrodt Pharmaceuticals are both market leaders. But they have different business models, sales channels, customers, capital requirements and employee talent bases. What’s more, their product pipelines differ substantially in length, regulatory approval and requirements, possible risks and potential returns. The separation gives both businesses much more flexibility to focus on their respective growth strategies. And at the same time, it potentially offers shareholders more long-term value.
We’re already a global healthcare leader. And we plan to continue expanding internationally too – particularly into emerging markets. So whether you want an inspiring role close to home, or to explore opportunities farther afield, there’s a good chance we’ll have something to interest you.
Mallinckrodt, the 'M' brand mark, the Mallinckrodt Pharmaceuticals logo and other brands are trademarks of a Mallinckrodt company. © 2014 Mallinckrodt.
Mallinckrodt Pharmaceuticals is a registered business name of Mallinckrodt plc, which is registered in Ireland as a public limited company with registration number 522227 and has its registered office at Damastown, Mulhuddart, Dublin 15, Ireland.